By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie Pharmaceuticals, Inc. (AERI) Announces Rhopressa Presentation At 2015 Meeting Of The Association For Ocular Pharmacology And Therapeutics 2/18/2015 1:40:45 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015 10:42:04 AM
Aerie Pharmaceuticals, Inc. (AERI) To Announce Fourth Quarter And Year End 2014 Financial Results And Host Conference Call On Monday, March 2, 2015 2/17/2015 12:26:21 PM
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs 2/10/2015 7:05:24 AM
Aerie Pharmaceuticals, Inc. (AERI) To Participate In Two Investor Conferences In February 2/3/2015 12:15:32 PM
Aerie Pharmaceuticals, Inc. (AERI) Announces Acceleration Of Expected Timeline For Reporting Efficacy Results From Phase 3 Registration Trial (“Rocket 1”) Of Rhopressa™ 1/12/2015 2:33:44 PM
Aerie Pharmaceuticals, Inc. (AERI) Added To NASDAQ Biotechnology Index (NBI) 12/16/2014 10:41:47 AM
Aerie Pharmaceuticals, Inc. (AERI) Completes Enrollment In Phase 3 Registration Trial ("Rocket 1") Of Rhopressa™, Novel Triple-Action Product To Lower Intraocular Pressure In Patients With Glaucoma 12/2/2014 8:56:23 AM
Aerie Pharmaceuticals, Inc. (AERI) To Present At Piper Jaffray 26th Annual Healthcare Conference 11/24/2014 10:42:07 AM
Aerie Pharmaceuticals, Inc. (AERI) Reports Third Quarter 2014 Financial Results And Provides Business And Product Development Update 11/12/2014 2:33:08 PM
123456
//-->